For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.

Researchers have traditionally employed histopathology techniques, which involve the microscopic examination of tissue, to gain insight into disease processes. This approach often leads to subjective ...